- Home
- ONCO vs DSS Comparison
ONCO vs DSS Comparison
Compare ONCO & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCO
- DSS
- Stock Information
- Founded
- ONCO 2018
- DSS 1984
- Country
- ONCO United States
- DSS United States
- Employees
- ONCO N/A
- DSS N/A
- Industry
- ONCO Biotechnology: Pharmaceutical Preparations
- DSS Containers/Packaging
- Sector
- ONCO Health Care
- DSS Consumer Discretionary
- Exchange
- ONCO Nasdaq
- DSS Nasdaq
- Market Cap
- ONCO 1.8M
- DSS 8.9M
- IPO Year
- ONCO 2022
- DSS N/A
- Fundamental
- Price
- ONCO $4.23
- DSS $0.90
- Analyst Decision
- ONCO
- DSS
- Analyst Count
- ONCO 0
- DSS 0
- Target Price
- ONCO N/A
- DSS N/A
- AVG Volume (30 Days)
- ONCO 229.9K
- DSS 189.3K
- Earning Date
- ONCO 08-28-2025
- DSS 08-12-2025
- Dividend Yield
- ONCO N/A
- DSS N/A
- EPS Growth
- ONCO N/A
- DSS N/A
- EPS
- ONCO N/A
- DSS N/A
- Revenue
- ONCO $1,925,313.00
- DSS $20,180,000.00
- Revenue This Year
- ONCO N/A
- DSS N/A
- Revenue Next Year
- ONCO N/A
- DSS N/A
- P/E Ratio
- ONCO N/A
- DSS N/A
- Revenue Growth
- ONCO 153.70
- DSS 12.88
- 52 Week Low
- ONCO $3.82
- DSS $0.72
- 52 Week High
- ONCO $1,190.00
- DSS $1.64
- Technical
- Relative Strength Index (RSI)
- ONCO 40.01
- DSS 49.74
- Support Level
- ONCO $4.19
- DSS $0.88
- Resistance Level
- ONCO $5.17
- DSS $0.92
- Average True Range (ATR)
- ONCO 0.45
- DSS 0.07
- MACD
- ONCO 0.07
- DSS -0.00
- Stochastic Oscillator
- ONCO 21.76
- DSS 45.87
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.